Want to see SE:POLYG full AI Analyst Report?
Top Page
Polygiene AB
(POLYG)
Select Model
Select Model
Rating:54Neutral
Price Target:
kr5.00
▼(-45.77% Downside)
Action:Reiterated
Date:07/25/26
Overall score reflects a financially stable but uneven operating profile: strong solvency and improving TTM revenue/cash flow are offset by still-weak profitability and historical volatility. Technicals weigh on the score due to a clear downtrend (below key moving averages with negative MACD), while valuation is mixed—high dividend yield helps, but the P/E remains elevated.
Positive Factors
Balance sheet strength
Very low leverage and a substantial equity cushion provide durable financial resilience. This conservative capital structure reduces refinancing and solvency risk, supporting the company's ability to fund operations, withstand cyclical revenue dips, and pursue selective partnerships without immediate external financing.
Negative Factors
Thin and volatile profitability
Margins near breakeven imply limited ability to absorb cost increases or fund growth organically. Historical swings—double-digit margins in some years but a loss in 2025—indicate structural margin sensitivity to volume, pricing, and mix. Persistent low margins constrain long-term return generation for shareholders.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet strength
Very low leverage and a substantial equity cushion provide durable financial resilience. This conservative capital structure reduces refinancing and solvency risk, supporting the company's ability to fund operations, withstand cyclical revenue dips, and pursue selective partnerships without immediate external financing.
Read all positive factors
Polygiene AB (POLYG) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr181.90M
Dividend Yield5.41%
Average Volume (3M)6.20K
Price to Earnings (P/E)62.1
Beta (1Y)0.07
Revenue Growth-14.23%
EPS Growth84.80%
CountrySE
Employees35
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)0.08
Shares Outstanding36,526,990
10 Day Avg. Volume5,228
30 Day Avg. Volume6,198
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)1.22
Price to Sales (P/S)2.30
P/FCF Ratio-30.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.71
Revenue Forecast (FY)kr168.80M
Polygiene AB Business Overview & Revenue Model
Company Description
Based in Malmö, Sweden, and founded in 2005, Polygiene Group AB develops, produces, and markets advanced solutions designed to control odors and maintain freshness across a wide range of materials. These applications extend to clothing, athletic e...
How the Company Makes Money
Polygiene makes money primarily by commercializing its proprietary odor-control and antimicrobial technologies to other businesses (a B2B model) rather than selling finished consumer products. Revenue is generated through the sale and licensing of...
Polygiene AB Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
82
Very Positive
Cash Flow
51
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 137.55M | 146.65M | 156.95M | 113.54M | 173.56M | 181.61M |
| Gross Profit | 56.59M | 48.32M | 103.78M | 77.16M | 114.57M | 115.24M |
| EBITDA | 5.87M | 5.96M | 18.80M | -305.61M | 19.10M | 43.99M |
| Net Income | 2.94M | -5.58M | 16.83M | -321.95M | 8.36M | 32.83M |
Balance Sheet | ||||||
| Total Assets | 322.26M | 304.74M | 350.84M | 313.78M | 621.90M | 550.69M |
| Cash, Cash Equivalents and Short-Term Investments | 50.26M | 38.78M | 68.59M | 44.15M | 48.06M | 52.40M |
| Total Debt | 2.29M | 4.57M | 2.63M | 3.89M | 1.64M | 2.40M |
| Total Liabilities | 37.18M | 28.56M | 31.23M | 22.53M | 29.34M | 31.54M |
| Stockholders Equity | 285.07M | 276.17M | 319.61M | 291.25M | 592.56M | 519.15M |
Cash Flow | ||||||
| Free Cash Flow | 9.25M | -11.04M | 22.75M | -4.27M | -50.64M | 34.15M |
| Operating Cash Flow | 11.47M | -9.79M | 24.34M | 3.79M | -1.54M | 37.60M |
| Investing Cash Flow | -3.79M | -4.07M | -1.59M | -9.42M | -52.11M | -407.47M |
| Financing Cash Flow | -4.65M | -9.67M | -1.38M | 1.95M | 47.50M | 416.27M |
Polygiene AB Technical Analysis
Negative
9.22
Price Trends
5.34
Negative
6.05
Negative
7.38
Negative
Market Momentum
-0.16
Negative
46.13
Neutral
24.61
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:POLYG, the sentiment is Negative. The current price of 9.22 is above the 20-day moving average (MA) of 4.97, above the 50-day MA of 5.34, and above the 200-day MA of 7.38, indicating a neutral trend. The MACD of -0.16 indicates Negative momentum. The RSI at 46.13 is Neutral, neither overbought nor oversold. The STOCH value of 24.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:POLYG.
Polygiene AB Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | kr181.90M | 62.06 | 1.04% | 2.89% | -14.23% | 84.80% | |
54 Neutral | kr317.73M | -17.28 | -8.17% | ― | -1.90% | -13.63% | |
52 Neutral | kr218.09M | -14.70 | -25.31% | ― | 69.39% | 35.69% | |
45 Neutral | kr87.76M | -1.33 | -166.81% | ― | -21.13% | -66.28% | |
40 Underperform | kr35.69M | -0.35 | -222.49% | ― | -19.45% | 79.90% |
* Basic Materials Sector Average
SE:POLYG
Polygiene AB
4.99
-4.55
-47.71%
SE:NEXAM
Nexam Chemical Holding AB
3.20
-0.74
-18.78%
SE:LCLEAN
LifeClean International AB
0.03
-0.08
-70.00%
SE:AXIC.A
aXichem AB Class A
3.58
0.91
34.08%
SE:ORGC
OrganoClick AB
0.44
-1.39
-75.97%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.